M&G Investment Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-290,473
Closed -$1.74M 412
2023
Q1
$1.74M Sell
290,473
-193,747
-40% -$1.28M 0.01% 291
2022
Q4
$2.91M Sell
484,220
-175,780
-27% -$1.1M 0.01% 261
2022
Q3
$3.96K Hold
660,000
0.02% 237
2022
Q2
$2.64K Hold
660,000
0.02% 277
2022
Q1
$5.28K Hold
660,000
0.01% 249
2021
Q4
$6.6K Hold
660,000
0.02% 238
2021
Q3
$7.92K Buy
660,000
+263,502
+66% +$3.66M 0.02% 314
2021
Q2
$5.55K Hold
396,498
0.01% 386
2021
Q1
$6.34K Hold
396,498
0.02% 215
2020
Q4
$6.34K Hold
396,498
0.04% 215
2020
Q3
$15.1M Sell
396,498
-299,240
-43% -$9.38M 0.15% 129
2020
Q2
$15.3M Sell
695,738
-14,456
-2% -$309K 0.16% 122
2020
Q1
$5.68M Sell
710,194
-35,513
-5% -$544K 0.07% 188
2019
Q4
$10.4M Buy
+745,707
New +$9.5M 0.09% 173

Other funds holding MESO

M&G Investment Management's MESO Position: Q2 2023 in Review

M&G Investment Management sold out of Mesoblast (MESO) in Q2 2023, closing a stake of 290,473 shares — an estimated $1.74M sold.

M&G Investment Management first reported a position in MESO in Q4 2019 and held it in 14 quarters. The position peaked at $15.3M in Q2 2020. 43 funds tracked by Wall St. Rank hold MESO as of Q2 2023.

  • M&G Investment Management reported no remaining Mesoblast position as of Q2 2023 after selling out during the quarter.
  • M&G Investment Management sold 290,473 Mesoblast shares in Q2 2023, an estimated $1.74M.
  • M&G Investment Management first reported a position in Mesoblast in Q4 2019 and held it in 14 quarters.
  • M&G Investment Management's Mesoblast position peaked at $15.3M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Mesoblast as of Q2 2023.

Based on M&G Investment Management's 13F filing for Q2 2023, filed 1 Aug 2023.